Conference Call:        Today, Thursday, April 30, 2009 at 10:00 a.m. EDT   Dial-in Numbers:        866-395-2657 or 706-902-0717 (international)        Webcast / Replay URL:   www.integramed.com or www.earnings.com              Phone Replay:           800-642-1687 or 706-645-9291 through May 7          Conference ID#:         94273749                                             -------------------------------------------------------------------------------  

IntegraMed America, Inc. (NASDAQ: INMD), the nation's leading provider of specialty healthcare services in emerging, technology-focused segments, today announced results for the first quarter ended March 31, 2009, reflecting strength across all three of the Company's business segments: fertility centers, consumer services and vein care. IntegraMed's revenues, contribution, income before income taxes and net income increased significantly over the year ago period.

                                                                                                                                                                                                                                                   Summary Financial Results (in thousands, except per share data)                                                                                                                                                                                                                   Q1 2009   Q1 2008(1)   % Change                                                                                                                                                                                 Revenues: Fertility Centers      $36,283   $32,746      11%                                                                                                                                                                                      Consumer Services                5,226     4,023        30%                                                                                                                                                                                      Vein Clinics                     10,846    8,842        23%                                                                                                                                                                                      Total revenues                   52,355    45,611       15%                                                                                                                                                                                      Contribution: Fertility Centers  2,640     2,304        15%                                                                                                                                                                                      Consumer Services                1,513     1,065        42%                                                                                                                                                                                      Vein Clinics                     754       322          134%                                                                                                                                                                                     Total contribution               4,907     3,691        33%                                                                                                                                                                                      G&A Costs                        3,138     2,363        33%                                                                                                                                                                                      Net Interest expense             220       279          (21%)                                                                                                                                                                                    Income before Inc Taxes          1,549     1,049        48%                                                                                                                                                                                      Net income                       $920      $621         48%                                                                                                                                                                                      EPS                              $0.10     $0.07        43%                                                                                                                                                                                      Diluted shares                   8,827     8,641        2%                                                                                                                                                                                       (1) As noted in our 2008 Form 10-K, IntegraMed's Q1 2008 results have been restated to reflect an accounting policy change with respect to the timing of revenue recognition for the Attain IVF program within the Consumer Services Division.    -------------------------------------------------------------------------------  

IntegraMed's Chief Executive Officer, Jay Higham, commented, "Our businesses continue to perform well in a challenging economic environment, reaffirming our strategy of focusing on emerging niche medical specialties. Our Vein Clinic segment turned in a strong performance in Q1 which validates our strategy to expand into that area of medical specialty and confirms both the growth potential and operating leverage this segment provides. We are seeing some slowing in new patient volumes in the Fertility Center segment of our business, reflecting demographic trends we have noted for a number of years, as well as some impact of the recession on consumer behavior. However, the suite of services we provide in combination with our operational agility have enabled us to perform well in spite of these factors. The strong year-over-year comparison reflects this as well as the benefit of new centers and affiliates added over the past year, along with an improvement in pregnancy rates in our Consumer Services segment.

"In addition to meeting our near-term financial obligations, we are focused on delivering growth over the long term by continuing our commitment to expand our Fertility Center, Consumer Services and Vein Clinics businesses and drive operational efficiency. Though we believe the IntegraMed platform of services is suitable for other areas of medical specialty, our near-term focus remains on building our existing businesses through the acquisition of additional fertility centers and the build-out of new vein clinic locations. Given the challenges and concerns many fertility centers may be experiencing due to the current environment, the value of a partnership with IntegraMed becomes all the more attractive.

"In an effort to further enhance our growth potential, we are also evaluating the possible acquisition of larger-scale fertility centers. Such transactions may require larger capital commitments by IntegraMed. However, we believe they would both accelerate growth and be immediately accretive to earnings. In summary, we believe we have the team and operating experience to manage through the current environment as well as the right strategies in place to grow the business for the long-term."

John Hlywak, CFO of IntegraMed, added, "Our operating units have responded to certain negative business trends with productive marketing initiatives as well as ongoing cost management efforts. Additionally, we are seeing some of the initial benefit of the strategic investments we made in our personnel and business infrastructure over the past year. While many of those investments are reflected in ongoing G&A which increased by 33% over last year, we were able to hold our G&A levels to 64% of contribution, the same percentage as last year."

Fertility Centers

Fertility Center revenues grew 11% to $36.3 million in Q1 ˜09 versus Q1 '08 and an increase of 6.3% versus Q4 '08. The increase was driven by a 7.6% rise in same-center fertility revenue as well as the addition of Southeastern Fertility in April 2008 and Arizona Reproductive Medical Associates in July 2008. The trend in new patient visits during the period, though well ahead of industry performance, did reflect some slow-down in demand. Revenue growth was spread across the US other than a few marginally challenged markets such as South Florida and Northern California.

Fertility Center contribution margin increased to 7.3% in Q1 '09 compared to 7.0% in Q1 '08, reflecting growing operating leverage.